A GLP-1R agonist (liraglutide) increased endothelial nitric oxide synthase phosphorylation and nitric oxide (NO) production by the 5-AMP-activated protein kinase (AMPK)-dependent pathway and subsequent NO production in cultured HCAEC [56],[57]
In order to work, semaglutide GLP-1 mimics the effects of GLP-1
Gastrointestinal side effects were the most frequently reported issue, with 64.4% of patients experiencing nausea and 45.4% reporting vomiting
Yes, targeted supplementation can significantly reduce risk and accelerate recovery, but only when youre addressing actual deficiencies or meeting increased demands during rapid weight loss
When someone applies for life insurance after losing weight on GLP-1 medications, underwriters see what looks like a healthy person with: Normal BMI Improved blood pressure Better cholesterol levels Lower HbA1c levels But here's the catch: Research from the landmark STEP 1 trial extension shows that participants regain approximately two-thirds of their prior weight loss within one year of stopping semaglutide (Wilding et al., 2022)
More recently, Arbabi et al.[38] demonstrated the effect of both GLP-1 and Ex4 in an experimental model of steroid-treated ovariectomized ewes
